Revolution Medicines (RVMDW) Deferred Taxes (2019 - 2024)
Revolution Medicines (RVMDW) posted quarterly Deferred Taxes of $762000.0 for Q4 2024, up 1672.09% year-over-year from $43000.0 in Q1 2024, and up 1672.09% quarter-over-quarter from $43000.0 in Q4 2023.
Revolution Medicines (RVMDW) Deferred Taxes (2019 - 2024) Analysis & Trends
Revolution Medicines' Deferred Taxes history runs 5 years deep, the most recent figure standing at $762000.0 for Q4 2024.
- In Q4 2024, Deferred Taxes rose 1672.09% year-over-year to $762000.0; the TTM figure through Dec 2024 stood at $928000.0 (up 580.83% YoY), while the FY2024 annual figure was $762000.0, down 80.51% from the prior year.
- Deferred Taxes for Q4 2024 stood at $762000.0, up from $43000.0 in the prior quarter.
- The five-year high for Deferred Taxes was $762000.0 in Q4 2024, with the low at -$359000.0 in Q4 2020.
- The 4-year median for Deferred Taxes is $83000.0 (2022), against an average of $217166.7.
- The sharpest annual moves came in 2020 and 2024: Deferred Taxes tumbled 107.56% in 2020, then jumped 1672.09% in 2024.
- Revolution Medicines' Deferred Taxes stood at -$359000.0 in 2020, then jumped by 134.26% to $123000.0 in 2022, then plunged by 65.04% to $43000.0 in 2023, then surged by 1672.09% to $762000.0 in 2024.
- Business Quant data shows RVMDW's Deferred Taxes at $762000.0 in Q4 2024, $43000.0 in Q4 2023, and $123000.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.66 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Revolution Medicines | 2.45 Bn | 2.45 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 762,000.00 |
| Dec 31, 2023 | 43,000.00 |
| Dec 31, 2022 | 123,000.00 |
| Dec 31, 2020 | -359,000.00 |
| Jun 30, 2020 | 18,000.00 |
| Mar 31, 2020 | 716,000.00 |
| Dec 31, 2019 | 4.75 Mn |
| Sep 30, 2019 | -141,000.00 |
| Jun 30, 2019 | -136,000.00 |
| Mar 31, 2019 | -96,000.00 |